Jack Elder, MD, FACS

Massachusetts General Hospital
  • Chief of Pediatric Urology

Jack S. Elder, M.D., FACS, is Chief of Pediatric Urology, Mass General. Dr. Elder received an M.D. with distinction from the University of Oklahoma College of Medicine, and was Vice President of Alpha Omega Alpha. He completed general surgery training at Yale-New Haven Hospital and a residency in urology, including chief resident, at The Johns Hopkins Hospital. Dr. Elder completed a pediatric urology fellowship at Johns Hopkins and at Children’s Hospital of Philadelphia. He was Director of Pediatric Urology at Rainbow Babies and Children’s Hospital for 21 years, and tenured Carter Kissell Professor of Urology at Case Western University School of Medicine. Subsequently, Dr. Elder was appointed Chief of Urology and Chief of Pediatric Urology, Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI.

Dr. Elder was the Pediatric Urology Section Editor of The Journal of Urology from 1998-2007. Currently, he is on the editorial board of European Urology, Pediatric Surgery International, BJU International, Annals of Urology, and International Scholarly Research Notices. Dr. Elder served as President of the Society for Pediatric Urology and the American Academy of Pediatric Urologists. He was the Chairman of the first American Urological Association Pediatric Vesicoureteral Reflux Guidelines Committee, and was the facilitator of the second AUA Reflux Guidelines Committee, which published updated recommendations in 2010. He also is the Section Head, Pediatric Urology, AUA Online Robotic Surgery Handbook and is an annual reviewer for the European Association of Urology Paediatric Urology Guidelines. Dr. Elder has been Visiting Professor or Visiting Surgeon at 54 U.S. and international medical centers. Dr. Elder has > 160 peer-reviewed publications, edited or authored 6 books, 150 book chapters, and writes the pediatric urology section of the Nelson Textbook of Pediatrics. He is listed in Boston Magazine 2016 Top Docs.

Michael Blute, Sr, MD

Massachusetts General Hospital
  • Chief of Urology

Dr. Michael L. Blute received his BA Degree from the College of the Holy Cross in Worcester, and his MD Degree from Creighton University School of Medicine in 1982, graduating Magna Cum Laude. Subsequent to internship and residency in urology at the Mayo Clinic in Rochester, he remained on the staff and rose rapidly through the ranks to become the Anson L. Clark Professor and Chairman in the Department of Urology in 1999. He remained as Chairman of the Department of Urology and on the Executive Board of the Mayo Clinic until appointed Interim Chief of Urology and Director of the Cancer Center of Excellence at the University of Massachusetts Memorial Medical Center in 2010. In April 2012 Dr. Blute was appointed Chief of Urology at The Massachusetts General Hospital in Boston.

Dr. Blute has had a major interest in urologic oncology and is well-known in the field of academic urology. His major areas of interest include prostate cancer, nephron-sparing surgery for kidney masses, and the management of complex renal cell and bladder neoplasms. He has been involved in phase III trials of Finasteride, chemoprevention of prostatic intraepithelial neoplasia with anti-androgens, minimally invasive surgery for BPH, biomarkers in prostate cancer, and localization of tumor suppressor genes in prostate cancer. He serves as a reviewer on 13 editorial boards. He serves on the AUA Renal Mass Guideline Panel and served on the American Joint Committee on Cancer. He is the recipient of the 2010 AUA Career Contribution Award. He has been honored as Department of Urology Teacher of the Year at the Mayo Clinic on several occasions. His bibliography includes 387 peer-reviewed publications, one book, and 26 book chapters.

Sign Up for Newsletter

"*" indicates required fields